Buscar resultados de ensayos clínicos
Poliomyelitis - 42 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants Condición: Poliomyelitis Fecha: 2015-01-15 Intervenciones:
|
Completed |
Nombre del estudio: Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine Condición: Poliomyelitis Fecha: 2016-05-25 Intervenciones: Biological: poliovirus vaccine Different vaccination schedules with bOPV, tOPV and cIPV would be provide |
Completed |
Nombre del estudio: Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults Condición: Poliomyelitis Fecha: 2012-10-15 Intervenciones:
|
Completed |
Nombre del estudio: Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV Condición:
Fecha: 2006-07-03 Intervenciones:
|
Recruiting |
Nombre del estudio: Safety and Immunogenicity of IPOVAC in Young Children Condición: Poliomyelitis Fecha: 2016-05-05 Intervenciones:
|
Withdrawn |
Nombre del estudio: A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome Condición: Postpoliomyelitis Syndrome Fecha: 2012-03-07 Intervenciones:
|
Terminated |
Nombre del estudio: Modafinil to Treat Fatigue in Post-Polio Syndrome Condición: Postpoliomyelitis Syndrome Fecha: 2003-08-20 Intervenciones: Drug: Modafinil |
Active, not recruiting |
Nombre del estudio: L-Citrulline in Patients With Post-Polio Syndrome Condición: Post-Polio Syndrome Fecha: 2016-06-06 Intervenciones:
|
Recruiting |
Nombre del estudio: Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome Condición: Post-polio Syndrome Fecha: 2014-06-25 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS) Condición: Post Polio Syndrome, PPS Fecha: 2005-09-09 Intervenciones: Drug: Xepol |